# Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection

> **NCT00180674** · PHASE2 · COMPLETED · sponsor: **Imperial College London** · enrollment: 14 (actual)

## Conditions studied

- Liver Fibrosis

## Interventions

- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT00180674
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2006-09
- **Final completion:** 2006-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2020-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00180674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00180674, "Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00180674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*